Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrafem 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Adley Formulations

Salt Composition

Letrozole (2.5mg)

Overview Letrafem 2.5 Tablet

Femlet 2.5mg tablets are indicated for managing breast cancer in women who have completed menopause. This medication can be administered independently or alongside other therapies like surgical intervention or radiotherapy. It's also employed in advanced breast cancer cases to inhibit metastasis. Femlet 2.5mg may be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal efficacy. Dosage adjustments are determined by the specific treatment objective. Your physician will tailor the regimen to alleviate symptoms effectively. Continue taking the medication as directed. Frequently reported adverse effects include vasomotor flushes, tiredness, diaphoresis, and elevated cholesterol. Report any concerning or persistent symptoms to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. Comprehensive disclosure of all concurrently used medications is crucial, as interactions may compromise effectiveness or alter the drug's action. Notify your doctor if you are pregnant or lactating. Pre- and post-treatment blood tests to monitor vitamin D levels and bone mineral density may be conducted.

Uses of Letrafem 2.5 Tablet

Managing breast cancer

Major Benefits of Letrafem 2.5 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrafem 2.5mg Tablets can be consumed with or without food; however, consistent timing is recommended.

Common Side effects of Letrafem 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrafem 2.5 Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Letrafem 2.5mg tablets can be consumed with or without food, though consistent timing is recommended.

How Letrafem 2.5 Tablet works:

Letrafem 2.5 mg tablets are classified as aromatase inhibitors. Their mechanism of action involves reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Letrafem 2.5 Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

Using Letrafem 2.5 Tablet during pregnancy poses a substantial risk. Pregnant women should consult their physician; research in both animal and human studies has revealed considerable adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Using Letrafem 2.5 Tablet while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingUNSAFE

Using Letrafem 2.5 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The use of Letrafem 2.5 Tablet is considered safe for individuals with kidney impairment, and no dosage modification is typically necessary. Data regarding its use in patients with end-stage renal disease is, however, scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Letrafem 2.5mg tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Letrafem 2.5 Tablet :

Should you forget a Letrafem 2.5 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letrafem 2.5 Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letrafem 2.5 Tablet

Letrafem 2.5 mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrafem 2.5 Tablet is an anti-estrogen medication. It works by inhibiting the aromatase enzyme, thereby lowering estrogen levels. Since estrogen fuels the growth of certain breast cancers—termed "estrogen-dependent cancers"—reducing estrogen production can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letrafem 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Letrafem 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letrafem 2.5 Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letrafem 2.5 Tablet can be taken together, monitor your blood pressure closely as Letrafem 2.5 Tablet may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrafem 2.5 Tablet may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Letrafem 2.5 Tablet, resulting from lowered estrogen levels. These typically lessen as your body adapts to the medication. However, for some, they may persist throughout treatment, subsiding several months afterward. If bothersome, consult your doctor for appropriate management.
Letrafem 2.5 Tablet may cause serious side effects, such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions, though these are uncommon.
Letrafem 2.5 Tablet can reduce bone density, increasing the risk of osteoporosis, because it lowers estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Letrafem 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Letrafem 2.5 Tablet
238